Unknown

Dataset Information

0

Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.


ABSTRACT: The increase in effective treatments using recombinant adeno-associated viral (rAAV) vectors has underscored the importance of scalable, high-yield manufacturing methods. Previous work from this group reported the use of recombinant herpes simplex virus type 1 (rHSV) vectors to produce rAAV in adherent HEK293 cells, demonstrating the capacity of this system and quality of the product generated. Here we report production and optimization of rAAV using the rHSV system in suspension HEK293 cells (Expi293F) grown in serum and animal component-free medium. Through adjustment of salt concentration in the medium and optimization of infection conditions, titers greater than 1?×?1014 vector genomes per liter (VG/liter) were observed in purified rAAV stocks produced in Expi293F cells. Furthermore, this system allowed for high-titer production of multiple rAAV serotypes (2, 5, and 9) as well as multiple transgenes (green fluorescent protein and acid ?-glucosidase). A proportional increase in vector production was observed as this method was scaled, with a final 3-liter shaker flask production yielding an excess of 1?×?1015 VG in crude cell harvests and an average of 3.5?×?1014 total VG of purified rAAV9 material, resulting in greater than 1?×?105 VG/cell. These results support the use of this rHSV-based rAAV production method for large-scale preclinical and clinical vector production.

SUBMITTER: Adamson-Small L 

PROVIDER: S-EPMC5346630 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.

Adamson-Small Laura L   Potter Mark M   Byrne Barry J BJ   Clément Nathalie N  

Human gene therapy methods 20170201 1


The increase in effective treatments using recombinant adeno-associated viral (rAAV) vectors has underscored the importance of scalable, high-yield manufacturing methods. Previous work from this group reported the use of recombinant herpes simplex virus type 1 (rHSV) vectors to produce rAAV in adherent HEK293 cells, demonstrating the capacity of this system and quality of the product generated. Here we report production and optimization of rAAV using the rHSV system in suspension HEK293 cells (E  ...[more]

Similar Datasets

| S-EPMC8195378 | biostudies-literature
| S-EPMC2650098 | biostudies-literature
2020-06-05 | GSE151811 | GEO
| S-EPMC10783082 | biostudies-literature
| S-EPMC275469 | biostudies-literature
| PRJNA338711 | ENA
| S-EPMC4236062 | biostudies-literature
2017-08-30 | GSE95716 | GEO
| S-EPMC2919046 | biostudies-literature
| S-EPMC4947914 | biostudies-literature